Breakdown of Tolerance to A Self-Peptide of Acetylcholine Receptor α-Subunit Induces Experimental Myasthenia Gravis in Rats

Journal of Immunology

Volumn 172, Issue 4, 2004, Pages 2697-2703

  Baggi, Fulvio ^a   Annoni, Andrea ^a   Ubiali, Federica ^a   Milani, Monica ^a,c   Longhi, Renato ^b   Scaioli, Widmer ^a   Cornelio, Ferdinando ^a   Mantegazza, Renato ^a   Antozzi, Carlo ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b Institute of Chemistry of Molecular Recognition   (Italy)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ALPHA SUBUNIT; CHOLINERGIC RECEPTOR ANTIBODY; EPITOPE; PEPTIDE; RECEPTOR SUBUNIT; TORPEDO CHOLINERGIC RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; AMINO ACID SEQUENCE; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CROSS REACTION; ELECTROPHYSIOLOGY; EPITOPE MAPPING; EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS; EXPERIMENTAL RAT; FEMALE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; LYMPHOCYTE PROLIFERATION; MEMBRANE DAMAGE; MYASTHENIA GRAVIS; NEUROIMMUNOLOGY; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NEUROPHYSIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TORPEDO;

EID: 0842300349     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.4.2697     Document Type: Article

References (29)

1. Christadoss, P., M. Poussin, and C. Deng. 2000. Animal models of myasthenia gravis. Clin. Immunol. 94:75.
2. Vincent, A. 2002. Unravelling the pathogenesis of myasthenia gravis. Nat. Rev. Immunol. 2:797.
3. Link, H., and B. G. Xiao. 2001. Rat models as tool to develop new immunotherapies. Immunol. Rev. 184:117.
4. Fujii, Y., and J. Lindstrom. 1988. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis: response to subunits and synthetic peptides. J. Immunol. 140:1830.
5. Zhang, Y., T. Barkas, M. Juillerat, B. Schwendimann, and H. Wekerte. 1988. T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the a chain of the nicotinic acetylcholine receptor (Torpedo californica). Eur. J. Immunol. 18:551.
6. Zhang, Y., S. Frutiger, G. J. Hughes, M. C. Savoy, and T. Barkas. 1990. Identification of T-cell epitopes of autoantigens using recombinant proteins: studies on experimental autoimmune myasthenia gravis. Immunology 71:538.
7. Lennon, V. A., E. H. Lambert, K. R. Leiby, T. B. Okarma, and S. Talib. 1991. Recombinant human acetylcholine receptor a-subunit induces chronic experimental autoimmune myasthenia gravis. J. Immunol. 146:2245.
8. Yoshikawa, H., E. H. Lambert, D. R. Walser-Kuntz, Y. Yasukawa, D. J. McCormick, and V. A. Lennon. 1997. A 17-mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis. J. Immunol. 159:1570.
9. Aharonov, A., R. Tarrab-Hazdai, I. Silman, and S. Fuchs. 1977. Immunochemical studies on acetylcholine receptor from Torpedo californica. Immunochemistry 14:129.
10. Pachner, A. R., and F. S. Kantor. 1982. Nerve stimulation test in murine experimental autoimmune myasthenia gravis. Ann Neurol. 11:48.
11. Lindstrom, J. M., B. L. Einarson, V. A. Lennon, and M. E. Seybold. 1976. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. J. Exp. Med. 144:726.
12. Lindstrom, J., B. Einarson, and S. Tzartos. 1981. Production and assay of antibodies to acetylcholine receptors. Methods Enzymol. 74:432.
13. Lindstrom, J., and B. Einarson. 1979. Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis. Muscle Nerve 2:173.
14. Tzartos, S. J., A. Kokla, S. L. Walgrave, and B. M. Conti-Tronconi. 1988. Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the a subunit. Proc. Natl. Acad. Sci. USA 85:2899.
15. McCormick, D. J., and M. Z. Atassi. 1984. Localization and synthesis of the acetylcholine-binding site in the α-chain of the Torpedo californica acetylcholine receptor. Biochem J. 224:995.
16. Takamori, M., S. Okumura, M. Nagata, and H. Yoshikawa. 1988. Myasthenogenic significance of synthetic α-subunit peptide 183-200 of Torpedo californica and human acetylcholine receptor. J. Neurol. Sci. 85:121.
17. Lennon, V. A., D. J. McCormick, E. H. Lambert, G. E. Griesmann, and M. Z. Atassi. 1985. Region of peptide 125-147 of acetylcholine receptor α subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies. Proc. Natl. Acad. Sci. USA 82:8805.
18. McCormick, D. J., G. E. Griesmann, Z. X. Huang, E. H. Lambert, and V. A. Lennon. 1987. Myasthenogenicity of human acetylcholine receptor synthetic α-subunit peptide 125-147 does not require intramolecular disulfide cyclization. J. Immunol. 139:2615.
19. Takamori, M., T. Hamada, and S. Okumura. 1992. Myasthenogenicity in the main immunogenic region of acetylcholine receptor as modified by conformational design: an approach to antigenic synthetic peptides. J. Neurol Sci. 109:182.
20. Takamori, M., S. Okumura, K. Komai, and R. Satake. 1990. Conformational modification enhances myasthenogenicity in synthetic peptide of acetylcholine receptor α-subunit. J. Neurol. Sci. 99:219.
21. Matsuo, H., M. Tsujihata, A. Satoh, G. Takeo, T. Yoshimura, and S. Nagataki. 1992. Myasthenogenicity of a human acetylcholine receptor α-subunit peptide: morphology and immunology. Muscle Nerve 15:282.
22. Hoedemaekers, A. C., J. J. Verschuuren, F. Spaans, Y. F. Graus, S. Riemersma, P. J. van Breda Vriesman, and M. H. De Baets. 1997. Age-related susceptibility to experimental autoimmune myasthenia gravis: immunological and electrophysiological aspects. Muscle Nerve 20:1091.
23. Sine, S. M., H. L. Wang, and N. Bren. 2002. Lysine scanning mutagenesis delineates structural model of the nicotinic receptor ligand binding domain. J. Biol. Chem. 277:29210.
24. Saoudi, A., I. Bernard, A. Hoedemaekers, B. Cautain, K. Martinez, P. Druet, M. De Baets, and J. C. Guery. 1999. Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats. J. Immunol. 162:7189.
25. Yeh, T. M., and K. A. Krolick. 1990. T cells reactive with a small synthetic peptide of the acetylcholine receptor can provide help for a clonotypically heterogeneous antibody response and subsequently impaired muscle function. J. Immunol. 144:1654.
26. Reizis, B., F. Mor, M. Eisenstein, H. Schild, S. Stefanovic, H. G. Rammensee, and I. R. Cohen. 1996. The peptide binding specificity of the MHC class II 1-A molecule of the Lewis rat, RT1. BI. Int. Immunol. 8:1825.
27. + T cell clone from a myasthenia gravis patient. J. Neuroimmunol. 46:57.
28. Curnow, J., L. Corlett, N. Willcox, and A. Vincent. 2001. Presentation by myoblasts of an epitope from endogenous acetylcholine receptor indicates a potential role in the spreading of the immune response. J. Neuroimmunol. 115:127.
29. Vincent, A., and N. Willcox. 1999. The role of T-cells in the initiation of autoantibody responses in thymoma patients. Pathol. Res. Pract. 195:535.